NOP5 project (Neuroptis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNOP5 project (Neuroptis)
Drug Alias NameNOP-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOcular inflammationXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuroptis Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuroptis Biotech
Active IndicationsN/A
Inactive IndicationsOcular inflammationXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A